Free Trial

Ovid Therapeutics (OVID) SEC Filings & 10K Form

Ovid Therapeutics logo
$1.06 -0.09 (-7.83%)
(As of 11/15/2024 ET)

Recent Ovid Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
5:01 PM
EcoR1 Capital, LLC (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G/A
09/11/2024
4:36 PM
ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
4:38 PM
ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:57 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:02 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:03 AM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
4:22 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
7:04 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
6:10 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:19 PM
Ovid Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2024
7:11 AM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:03 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:57 PM
Ovid Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:59 PM
Ovid Therapeutics (Filer)
Form DEFA14A
04/24/2024
4:00 PM
Ovid Therapeutics (Filer)
Form ARS
03/20/2024
4:22 PM
LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:20 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
7:24 AM
Ovid Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
4:54 PM
Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
4:56 PM
Fitzgerald Kevin Joseph (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
4:57 PM
Friedman Bart (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
4:58 PM
LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
5:00 PM
Ovid Therapeutics (Issuer)
Perone Thomas Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
5:01 PM
Ovid Therapeutics (Issuer)
Poole Robert Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
5:03 PM
Ovid Therapeutics (Issuer)
Rona Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
5:05 PM
Ovid Therapeutics (Issuer)
Tardio Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
5:06 AM
Ovid Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G
12/06/2023
4:05 PM
LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
4:08 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OVID) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners